Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
James Comer to accuse Tim Walz of being...
Expired Obamacare subsidy deal inches toward Senate floor...
JONATHAN TURLEY: Impeachment obsession returns as Democrats recycle...
Rep LaMalfa’s death further shrinks Republican House majority
China bans military-use exports to key US ally...
From sanctions to seizure: What Maduro’s capture means...
Scathing audit reveals more fraud concerns inside top...
Emmer warns Walz could end up ‘in cuffs’...
Trump admin’s new nutrition guidelines target ultra-processed foods,...
Graham warns Iranian ayatollah: ‘Trump is gonna kill...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

by admin September 4, 2025
September 4, 2025
Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

The Restoration of America Foundation (ROAF) is calling on the Senate Finance Committee to hold Health and Human Services Secretary Robert F. Kennedy Jr. accountable at Thursday’s 10 a.m. hearing, demanding answers about the removal of safety protocols for the abortion pill mifepristone.

In a letter provided exclusively to Fox News Digital, ROAF argues the rollback leaves women more vulnerable and shifts costs to taxpayers.

ROAF argues that the Biden-era rollback of Risk Evaluation and Mitigation Strategy (REMS) requirements, safeguards in place for more than two decades, endangers women by allowing abortion pills to be prescribed via telehealth and delivered through the mail.

‘The removal of key Risk Evaluation and Mitigation Strategy (REMS) requirements for mifepristone has eliminated essential safeguards that protected women’s health for over two decades,’ said Doug Truax, founder and CEO of the Restoration of America Foundation. ‘We urge the Senate to demand clear answers about why these safety protocols were removed and when they will be reinstated.’

The Food and Drug Administration originally required mifepristone to be dispensed in person to ensure women were screened for potential complications such as ectopic pregnancy. That changed under the Biden administration, when telehealth prescribing and mail-order delivery were permitted for the first time.

Truax warned that ‘allowing these powerful drugs to be ordered online and sent through the mail without proper medical screening puts women at serious risk.’ He added, ‘Women deserve to know about potential complications and have immediate access to emergency care if needed.’

This post appeared first on FOX NEWS

previous post
US bolsters military presence in Caribbean near Venezuela amid Trump’s efforts to halt drug trafficking
next post
Trump’s political advisors huddle with House GOP over rebranding of the big beautiful bill

You may also like

EXCLUSIVE: Charlie Kirk’s final book battles the ‘machine...

December 5, 2025

DOJ suddenly located Biden biographer transcripts created by...

August 15, 2024

‘Our position is clear:’ Zelenskyy and EU dismiss...

August 18, 2025

FBI investigating Iran’s hack of Trump campaign documents

August 13, 2024

Government limps deeper into shutdown crisis with no...

October 7, 2025

Israel’s Minister of Defense cancels visit to Pentagon...

October 10, 2024

Living US presidents react to death of former...

December 30, 2024

State Department to begin mass layoffs of about...

July 11, 2025

‘No reason’ for new nukes: Trump floats disarmament...

February 14, 2025

How close was Iran to a nuclear weapon...

June 14, 2025

Recent Posts

  • James Comer to accuse Tim Walz of being ‘asleep at the wheel’ at fraud hearing
  • Expired Obamacare subsidy deal inches toward Senate floor vote amid bipartisan talks
  • JONATHAN TURLEY: Impeachment obsession returns as Democrats recycle lawfare to fire up their base
  • Rep LaMalfa’s death further shrinks Republican House majority
  • China bans military-use exports to key US ally as Taiwan tensions rise

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (964)
    • Investing (3,814)
    • Politics (4,611)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.